Browsing Tag
intranasal drug delivery
3 posts
How intranasal delivery could reshape Clearmind Medicine Inc.’s MEAI development strategy in addiction
Find out how Clearmind Medicine Inc.’s intranasal MEAI strategy could reshape addiction drug development risk and execution.
Phase 2 trial of Nasus Pharma’s NS002 needle-free epinephrine starts with initial dosing milestone
Find out how Nasus Pharma is advancing NS002, its needle-free intranasal epinephrine candidate, into Phase 2 trials and what it means for emergency allergy care.
What makes Aptar Pharma’s latest nasal drug delivery bet a potential market disruptor?
Aptar Pharma teams up with Dianosic to advance a bioresorbable nasal scaffold platform for chronic sinus and rhinitis care. Find out how this could reshape treatment.